Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients

Supportive Care in Cancer

Volumn 21, Issue 10, 2013, Pages 2733-2742

  Marková, Markéta ^a   Brodská, Helena ^b   Malíčková, Karin ^b   Válková, Veronika ^a   Cetkovský, Petr ^a   Kolář, Michal ^a   Haluzík, Martin ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

C reactive protein; Hemato oncological patient; Hematopoietic stem cell transplantation; Mycosis; Procalcitonin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; FLUCONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; PROCALCITONIN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTICAL EQUIPMENT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANDIDIASIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EARLY INTERVENTION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION; INFECTIOUS COMPLICATION; INVASIVE ASPERGILLOSIS; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUTROPENIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TURBIDIMETRY;

ADULT; AGED; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; FEVER; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; ROC CURVE; YOUNG ADULT;

EID: 84884280163     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1844-1     Document Type: Article

References (38)

1. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer, Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7-14
2. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS, the CLSI Subcommittee for Antifungal Testing (2011) Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat(Feb 23)
3. Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Moore CB, Bowyer P, Perlin DS (2011) High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52(9):1123-1129
4. Howard SJ, Arendrup MC (2011) Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 49(Suppl 1):S90-S95
5. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ (2004) Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190(3):641-649
6. Maertens J, Buvé K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, Van Eldere J, Lagrou K (2009) Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115(2):355-362
7. Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ (2007) Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 195(3):455-466
8. Becker MJ, de Marie S, Willemse D, Verbrugh HA, Bakker-Woudenberg IA (2000) Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 38(4):1434-1438
9. Buchheidt D, Hummel M (2005) Aspergillus polymerase chain reaction (PCR) diagnosis. Med Mycol 43(Suppl 1):S139-S145
10. Khot PD, Ko DL, Hackman RC, Fredricks DN (2008) Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis 8:73
11. Vincent JL, Donatelo K, Schmidt X (2011) Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 27:241-251
12. Reinhard K, Meisner M (2011) Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 27:253-263
13. Ortega M, Rovira M, Filella X, Almela M, Puig de la Bellacasa J, Carreras E, Mensa J (2004) Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 126(3):372-376
14. Christofilopoulou S, Charvalos E, Petrikkos G (2002) Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 13(8):493-495
15. Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL (2005) Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 24(4):272-275
16. Charles PE, Dalle F, Aho S, Quenot JP, Doise JM, Aube H, Olsson NO, Blettery B (2006) Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 32(10):1577-1583
17. Hambach L, Eder M, Dammann E, Schrauder A, Sykora KW, Dieterich C, Kirschner P, Novotny J, Ganser A, Hertenstein B (2002) Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 87(6):643-651
18. Gérard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Y, Wattré P (1995) High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 23(5):310-311
19. Beaune G, Bienvenu F, Pondarré C, Monneret G, Bienvenu J, Souillet G (1998) Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection 26(3):168-169
20. Halekoh U, Højsgaard S, Yan J (2006) The R package geepack for generalized estimating equations. J Stat Softw 15(2):1-11
21. Siegel S, Castellan NJ (1988) Nonparametric statistics for the behavioral sciences, 2nd edn. McGraw-Hill, New York
22. Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE (2000) Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 7(6):889-892
23. Dornbusch HJ, Strenger V, Kerbl R, Lackner H, Schwinger W, Sovinz P, Urban C (2005) Procalcitonin - a marker of invasive fungal infection? Support Care Cancer 13(5):343-346
24. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60(6):425-430
25. Montagna MT, Coretti C, Caggiano G (2011) Procalcitonin: a possible marker of invasive fungal infection in high risk patients? J Prev Med Hyg 52(1):38-39
26. Charles PE, Tinel C, Barbar S, Aho S, Prin S, Doise JM, Olsson NO, Blettery B, Quenot JP (2009) Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 13(2):R38
27. Suberviola B, Castellanos-Ortega A, González-Castro A, García-Astudillo LA, Fernández-Miret B (2012) Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Med Intensiva 36(3):177-184
28. Simon L, Gauvin F, Saint Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206-217
29. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515-518
30. Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36(3):941-952
31. Schuetz P, Christ-Crain M, Müller B (2007) Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care 13(5):578-585
32. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, ProHOSP Study Group (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059-1066
33. Tang H, Huang T, Jing J, Shen H, Cui W (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 37(6):497-507
34. Bucova M, Zahorec R, Buc M (2006) Immunomodulatory effect of recombinant human procalcitonin on mitogenic activity of lymphocytes. Cent Eur J Immunol 31(3-4):87-93
35. Wei JX, Verity A, Garle M, Mahajan R, Wilson V (2008) Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary artery. Br J Anaesth 100(5):612-621
36. Liappis AP, Gibbs KW, Nylen ES, Yoon B, Snider RH, Gao B, Becker KL (2011) Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res 60(2):203-207
37. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W (2002) Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 30(9):2091-2095
38. Becker KL, Nylén ES, Snider RH, Müller B, White JC (2003) Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 9(6):367-374